Floatz logo

scg142 tcr-t cells

Vaginal Cancer

The Affiliated Hospital of Qingdao UniversityCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Vaginal Cancer cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Christian Hinrichs
Phase 2BB
Fludarabine
Christian Hinrichs
Phase 2BB
Octreotide Pamoate
Alliance for Clinical Trials in Oncology
Phase 3B
Durvalumab
M.D. Anderson Cancer Center
Phase 2B
e7 tcr-t cells
Christian Hinrichs
Phase 2B

View all 27 →

Same molecule, other indications

scg142 tcr-t cells is also rated in:

human papillomavirus-related squamous cell carcinomaDormant
CC
Indicative ·
43 / 100
View asset →
head and neck cancerDormant
CC
Indicative ·
43 / 100
View asset →
vulva cancerDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →